Exploration of an instrument measuring outcomes most important to patients through analysis of Overture data

Abstract

Background: The OVERTURE (NCT03556280) randomized controlled trial (RCT) evaluated Spectris TM in mild‐moderate Alzheimer’s disease (AD) ¹ , and collected functional and cognitive outcomes using several validated, clinically relevant instruments.

The paper